Literature DB >> 19598067

Combined Factor V and Factor VIII Deficiency.

Marta Spreafico1, Flora Peyvandi.   

Abstract

Combined deficiency of factor V (FV) and factor VIII (FVIII) (F5F8D, or FV+FVIII) is a autosomal recessive bleeding disorder caused by mutations in genes encoding two components of the endoplasmic reticulum (ER)-Golgi intermediate compartment (ERGIC-53), that is, lectin mannose binding protein ( LMAN1) and multiple coagulation factor deficiency 2 ( MCFD2), involved in the FV and FVIII intracellular transport rather than by DNA defects in the genes that encode the corresponding coagulation factors. F5F8D is estimated to be extremely rare (1:1,000,000) in the general population, but an increased frequency is observed in regions where consanguineous marriages are practiced. F5F8D is characterized by concomitantly low levels (usually between 5% and 20%) of both FV and FVIII and is associated with a mild to moderate bleeding tendency. Treatment of bleeding episodes requires a source of both FV and FVIII; replacement of FV is achieved only through use of fresh-frozen plasma (FFP) and replacement of FVIII by FFP and desmopressin or specific FVIII concentrates (plasma-derived or recombinant FVIII products).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19598067     DOI: 10.1055/s-0029-1225761

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  13 in total

Review 1.  Golgi glycosylation and human inherited diseases.

Authors:  Hudson H Freeze; Bobby G Ng
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-09-01       Impact factor: 10.005

2.  Enhanced biosynthesis of coagulation factor VIII through diminished engagement of the unfolded protein response.

Authors:  Harrison C Brown; Bagirath Gangadharan; Christopher B Doering
Journal:  J Biol Chem       Date:  2011-05-23       Impact factor: 5.157

Review 3.  Combined deficiency of coagulation factors V and VIII: an update.

Authors:  Chunlei Zheng; Bin Zhang
Journal:  Semin Thromb Hemost       Date:  2013-07-12       Impact factor: 4.180

4.  EF-hand domains of MCFD2 mediate interactions with both LMAN1 and coagulation factor V or VIII.

Authors:  Chunlei Zheng; Hui-hui Liu; Jiahai Zhou; Bin Zhang
Journal:  Blood       Date:  2009-12-09       Impact factor: 22.113

5.  Protein interaction profiling of the p97 adaptor UBXD1 points to a role for the complex in modulating ERGIC-53 trafficking.

Authors:  Dale S Haines; J Eugene Lee; Stephen L Beauparlant; Dane B Kyle; Willem den Besten; Michael J Sweredoski; Robert L J Graham; Sonja Hess; Raymond J Deshaies
Journal:  Mol Cell Proteomics       Date:  2012-02-14       Impact factor: 5.911

Review 6.  The COPII pathway and hematologic disease.

Authors:  Rami Khoriaty; Matthew P Vasievich; David Ginsburg
Journal:  Blood       Date:  2012-05-14       Impact factor: 22.113

7.  Interactions between glucocorticoid treatment and cis-regulatory polymorphisms contribute to cellular response phenotypes.

Authors:  Joseph C Maranville; Francesca Luca; Allison L Richards; Xiaoquan Wen; David B Witonsky; Shaneen Baxter; Matthew Stephens; Anna Di Rienzo
Journal:  PLoS Genet       Date:  2011-07-07       Impact factor: 5.917

Review 8.  Clinical practice: the bleeding child. Part II: disorders of secondary hemostasis and fibrinolysis.

Authors:  Femke van Herrewegen; Joost C M Meijers; Marjolein Peters; C Heleen van Ommen
Journal:  Eur J Pediatr       Date:  2011-09-17       Impact factor: 3.183

9.  Combined factor V and VIII deficiency in a young woman with abundant bleeding after tooth extraction.

Authors:  Ihsan Ates; Mustafa Kaplan; Gul Tokgoz; Funda Ceran; Simten Akalın; Gulsum Ozet
Journal:  Blood Res       Date:  2016-03-25

10.  Autosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions.

Authors:  Arshi Naz; Muhammad Younus Jamal; Samina Amanat; Ikram Din Ujjan; Akber Najmuddin; Humayun Patel; Fazle Raziq; Nisar Ahmed; Ayisha Imran; Tahir Sultan Shamsi
Journal:  Orphanet J Rare Dis       Date:  2017-04-07       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.